BLFS (NASDAQ) affiliate notifies sale of 250,000 shares via BMO Capital Markets
Rhea-AI Filing Summary
BioLifesolutions, Inc. notice of proposed sale of 250,000 shares of Common Stock under a Form 144 by an affiliate. The filing shows the shares were purchased from the issuer on 08/13/2018 and lists a prior sale of 300,000 shares on 05/19/2026 with gross proceeds of $6,795,000.00. The broker identified is BMO Capital Markets and the securities are listed on NASDAQ.
Positive
- None.
Negative
- None.
Insights
Routine Form 144 notice for an affiliate sale; disclosure-focused, not an execution report.
This Form 144 provides the required notice that an affiliate intends to sell 250,000 shares of Common Stock; it records the original purchase date as 08/13/2018. The filing names BMO Capital Markets as broker-dealer and lists a recent sale of 300,000 shares on 05/19/2026 with gross proceeds of $6,795,000.00.
The legal significance is disclosure under resale rules for affiliates; timing and completion of the proposed sale are not stated. Subsequent transaction reports or broker confirmations will show whether the intended sale executed.
Key Figures
Key Terms
Form 144 regulatory
affiliate regulatory
broker-dealer financial
AI-generated analysis. How Rhea-AI works. Not financial advice.